Wall Street brokerages predict that Cooper Companies Inc (NYSE:COO) will report sales of $581.18 million for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Cooper Companies’ earnings. The highest sales estimate is $587.20 million and the lowest is $569.50 million. Cooper Companies posted sales of $499.10 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 16.4%. The business is expected to report its next earnings report on Thursday, March 1st.

According to Zacks, analysts expect that Cooper Companies will report full year sales of $581.18 million for the current fiscal year, with estimates ranging from $2.49 billion to $2.66 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $2.67 billion per share, with estimates ranging from $2.57 billion to $2.82 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Cooper Companies.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating analysts’ consensus estimates of $2.64 by $0.01. The firm had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. Cooper Companies’s revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.28 earnings per share.

A number of research analysts have weighed in on the stock. Zacks Investment Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, January 8th. Robert W. Baird set a $273.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a research note on Monday, October 16th. Raymond James Financial reiterated a “buy” rating and set a $265.00 price objective on shares of Cooper Companies in a research note on Monday, December 4th. BMO Capital Markets reiterated a “buy” rating and set a $272.00 price objective on shares of Cooper Companies in a research note on Friday, October 13th. Finally, Oppenheimer set a $250.00 price objective on shares of Cooper Companies and gave the company a “hold” rating in a research note on Friday, December 8th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies has an average rating of “Buy” and an average price target of $259.70.

Shares of Cooper Companies (COO) traded up $0.12 during mid-day trading on Tuesday, reaching $230.96. 488,489 shares of the company’s stock were exchanged, compared to its average volume of 527,660. The firm has a market capitalization of $11,280.00, a PE ratio of 30.71, a price-to-earnings-growth ratio of 1.87 and a beta of 0.54. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36. Cooper Companies has a 1 year low of $177.06 and a 1 year high of $256.39.

The company also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio is currently 0.80%.

In related news, CEO Robert S. Weiss sold 32,500 shares of Cooper Companies stock in a transaction on Monday, December 18th. The shares were sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the sale, the chief executive officer now owns 119,111 shares in the company, valued at $26,764,241.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stanley Md Zinberg sold 5,000 shares of Cooper Companies stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $224.66, for a total transaction of $1,123,300.00. Following the completion of the sale, the director now owns 6,090 shares of the company’s stock, valued at approximately $1,368,179.40. The disclosure for this sale can be found here. Insiders have sold 54,385 shares of company stock worth $12,289,463 in the last quarter. Insiders own 1.60% of the company’s stock.

Several large investors have recently modified their holdings of the stock. Bank of Montreal Can increased its stake in shares of Cooper Companies by 26.7% in the fourth quarter. Bank of Montreal Can now owns 107,677 shares of the medical device company’s stock worth $23,460,000 after buying an additional 22,722 shares during the last quarter. Atria Investments LLC increased its stake in shares of Cooper Companies by 14.2% in the fourth quarter. Atria Investments LLC now owns 2,233 shares of the medical device company’s stock worth $487,000 after buying an additional 277 shares during the last quarter. Parametric Portfolio Associates LLC increased its stake in shares of Cooper Companies by 17.5% in the third quarter. Parametric Portfolio Associates LLC now owns 71,701 shares of the medical device company’s stock worth $17,001,000 after buying an additional 10,677 shares during the last quarter. AXA increased its stake in shares of Cooper Companies by 3.0% in the third quarter. AXA now owns 193,969 shares of the medical device company’s stock worth $45,992,000 after buying an additional 5,725 shares during the last quarter. Finally, GSA Capital Partners LLP increased its stake in shares of Cooper Companies by 354.8% in the third quarter. GSA Capital Partners LLP now owns 6,449 shares of the medical device company’s stock worth $1,529,000 after buying an additional 5,031 shares during the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Cooper Companies Inc (COO) Expected to Announce Quarterly Sales of $581.18 Million” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/16/cooper-companies-inc-coo-expected-to-announce-quarterly-sales-of-581-18-million-2.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Get a free copy of the Zacks research report on Cooper Companies (COO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.